Assessing ICS responsiveness in severe asthma using BDP/formoterol NEXThaler? dose-counting - Milan 2023

Novel research data on asthma management and clinical applications

Chair(s): Manali Mukherjee, Vibeke Backer

Session type: Poster session

Assessing ICS responsiveness in severe asthma using BDP/formoterol NEXThaler? dose-counting

Hnin Wint Aung

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Short-acting ?2-agonists over-prescription in patients with asthma: an Indian subset analysis of international SABINA III study.

Latha Sarma

Poster

Abstract

Quality of life in Greek asthmatic patients receiving FDC Budesonide/Formoterol as maintenance and/or as-needed treatment. The NOTOS study

Maria Bertoli

Poster

Abstract

Late Breaking Abstract - Efficacy and safety of benralizumab in patients with severe uncontrolled asthma despite ICS-LABA: a randomised, double-blind, placebo-controlled phase 3 trial in Asia (MIRACLE)

Kefang Lai

Poster

Abstract

Late Breaking Abstract - Patients with severe eosinophilic asthma achieved remission over 2 years with benralizumab: Integrated analysis of the >1000-patient, multinational, real-world XALOC-1 study

Girolamo Pelaia

Poster

Abstract

Late Breaking Abstract - An innovative inhaled solution of budesonide-cyclodextrin complex is safe and prevents the methacholine-induced hyperreactivity in asthmatics better than a commercial budesonide suspension: a breezy story (BOREAS).

Didier Cataldo

Poster

Abstract

Does bronchodilator responsiveness depend on age in asthma?

Rim Kammoun

Abstract

Extent and impact of SABA inhaler overuse among asthma patients in India

Sundeep Santosh Salvi

Poster

Abstract

Early effects of anti-IL4R on cognitive functions in patients with severe asthma.

Charlotte Bernhoff

Poster

Abstract

Characteristics of patients with asthma using single inhaler triple therapy (SITT) in the USA

Stephen G Noorduyn

Poster

Abstract

Asthma control in Greek patients receiving FDC of Budesonide/Formoterol as maintenance and/or as-needed treatment. The NOTOS study

Maria Bertoli

Poster

Abstract

Severe asthma care trajectories in the French RAMSES cohort.

Camille Taille

Poster

Abstract

Effectiveness and cost of a comprehensive severe asthma management strategy guided by airway inflammometry

Owen Treleaven

Poster

Abstract

Biologic agents licensed for severe asthma: A systematic review and meta-analysis of randomised controlled trials

Dimitrios Potonos

Poster

Abstract

Intramuscular triamcinolone for access to biologic therapy in asthma- a retrospective cohort analysis

Alexander Chadwick

Poster

Abstract

Assessing ICS responsiveness in severe asthma using BDP/formoterol NEXThaler dose-counting

Hnin Wint Aung

Poster

Abstract

Dupilumab is effective in real-life severe asthma patients with smoking history

Andreas Renner

Abstract

Bronchodilator effect of oral doxofylline and procaterol in asthma: a randomized crossover study

Natthapon Noomon

Poster

Abstract

Use of short synacthen testing to detect iatrogenic adrenal insufficiency among severe asthma patients

Fred Fyles

Poster

Abstract

Adherence to inhaled corticosteroid therapy and treatment escalation of the Swedish asthma population

Sylvia Packham

Poster

Abstract

Real life biological therapy effectiveness in patients with severe eosinophilic asthma: a comparison with randomized trial

Giulia Lo Muzio

Poster

Abstract

CDN Connection Issue

The ERS International Congress 2023, Milan

#{title}